NCT06083454 2026-03-13
Ascorbate With Durvalumab in Non-Small Cell Lung Cancer (NSCLC)
University of Iowa
Phase 1 Terminated
University of Iowa
Centre hospitalier de l'Université de Montréal (CHUM)
Centre Hospitalier Universitaire Vaudois
Fox Chase Cancer Center
National Cancer Institute (NCI)